α-tocopherol supplementation prevents lead acetate and hypoxia-induced hepatic dysfunction

Area of Science:

• Toxicology
• Environmental Health
• Biochemistry

Background:

• Lead (Pb) is a known environmental and industrial toxin that causes cellular damage, genetic alterations, and oxidative stress.
• Chronic exposure to lead and hypoxia can negatively impact cellular function and lead to significant health issues.

Purpose of the Study:

• To investigate the effects of chronic hypoxia or lead acetate exposure, alone or in combination, on hepatic oxidative and nitrosative stress in rats.
• To evaluate the protective role of α-tocopherol supplementation against these induced stresses.

Main Methods:

• Rats were exposed to chronic hypoxia (10% oxygen) or lead acetate (25 mg/kg) alone or combined, with or without α-tocopherol (10 mg/100 g) supplementation.
• Measurements included body weight, serum lipid profile, oxidant/antioxidant status, hypoxia-inducible factor-1 alpha (HIF-1α), vascular endothelial growth factor (VEGF), and histopathological examination of liver tissue.

Main Results:

• Lead and hypoxia exposure led to decreased body weight, altered lipid profiles, and impaired oxidant/antioxidant status, along with changes in HIF-1α and VEGF levels.
• Histopathological analysis revealed hepatic degenerative changes following exposure to lead or hypoxia.
• α-tocopherol supplementation demonstrated beneficial effects, mitigating these alterations and showing remarkable improvement in liver tissue.

Conclusions:

• α-tocopherol supplementation is effective in counteracting lead acetate and hypoxia-induced hepatic cytotoxicities.
• The protective mechanism of α-tocopherol likely involves the reduction of oxidative and nitrosative stress in the liver.